Betamethasone/Calcipotriol

倍他米松/卡泊三醇

Report date: 2026/04/17 20:02:02

Base Information

Drug NameBetamethasone/Calcipotriol
Drug Alias NameCalcipotriol/Betamethasone卡泊三醇倍他米松倍他米松卡泊三醇Calcipotriol and Betamethasone卡泊三醇/倍他米松 +[8
ClassificationSmall molecules > Steroids
Mechanisms of ActionVitamin D receptor antagonistsGlucocorticoid receptor agonists
TargetsGlucocorticoid receptorVitamin D receptor
Therapy Area/IndicationsPsoriasisRosaceaSkin and Connective Tissue Diseases +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesGermany +[5
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesLipidor AB
Active IndicationsPsoriasis
Inactive IndicationsRosaceaSkin and Connective Tissue DiseasesArthritis

Other Information

ATC CodeD05AX52
Related LinksN/A